There’s definitely a stronger emphasis on clinical facing companies in the Philadelphia-based University City Science Center Digital Health Accelerator’s second batch of startups. Between companies like Invis Alert Solutions with a wearable for institutional settings and Oncora Medical’s personalized cancer radiotherapy only one, GraphWear Technologies, seems to be a direct to consumer model. Half of the companies are women or minority owned.
For a digital health accelerator that only got started at the end of 2014, the inaugural class of University City Science Center’s accelerator has done pretty well. JMC Investment, part of a French American firm JMC Family Office, took a majority stake in French medical imaging business Keosys last fall. Launched in 2001, Keosys was no doubt the most mature of the accelerator participants. Fit.ly is gearing up for an appearance on Shark Tank next week. Between them, the seven companies created 68 jobs.
The inaugural class and second class have something in common — they’re peppered with alumni from DreamIt Health‘s accelerator.
Market Trends to Watch for Health Systems and Their Specialty Pharmacies
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.
Here is a summary of the participants:
Grand Round Table emails primary care providers a daily summary about their scheduled patient follow-ups so they can better manage high-risk patients, keeping them out of the hospital. It also joined athenahealth’s More Disruption Please program last year.
Graphwear Technologies developed the first graphene patch which measures dehydration, glucose, and lactic acid levels, all from your sweat.
InvisAlert Solutions uses a wearable device to help care providers monitor patients in institutional settings, improving compliance.
The Funding Model for Cancer Innovation is Broken — We Can Fix It
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Oncora Medical has a tool for planning personalized cancer radiotherapy, reduces the incidence of toxic radiation side effects in patients and improves cancer center efficiency.
One Health Company is a bit of an outsider here in that it helps to enroll ill pets in clinical trials of cutting-edge therapies. By improving their wellness, the goal is to help develop new therapies for human medicine.
Tissue Analytics transforms the smartphone into a platform for evaluating and measuring things like chronic wounds, burns, and skin conditions.
Photo: Flickr user vic15